MATTHEW JAMES SCHUCHERT
Medical Practice in Pittsburgh, PA

License number
Pennsylvania MX020484
Category
Medicine
Type
Written Agreement
Address
Address
Pittsburgh, PA 15213

Professional information

Matthew J Schuchert Photo 1

Dr. Matthew J Schuchert, Pittsburgh PA - MD (Doctor of Medicine)

Specialties:
Cardiac Surgery
Address:
200 Lothrop St STE C800, Pittsburgh 15213
(412) 623-2025 (Phone)
UPMC Thoracic Surgery
5200 Centre Ave STE 715, Pittsburgh 15232
(412) 623-2025 (Phone)
5115 Centre Ave, Pittsburgh 15232
Conditions:
Congestive Heart Failure
Certifications:
General Surgery, 2003, Thoracic Cardiovascular Surgery, 2007
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
200 Lothrop St STE C800, Pittsburgh 15213
5115 Centre Ave, Pittsburgh 15232
UPMC Thoracic Surgery
5200 Centre Ave STE 715, Pittsburgh 15232
UPMC Passavant - McCandless
9100 Babcock Blvd, Pittsburgh 15237
Education:
Medical School
Johns Hopkins University School Of Medicine
Graduated: 2002


Matthew Schuchert Photo 2

Matthew Schuchert, Pittsburgh PA

Work:
Hillman Cancer Center
5115 Centre Ave, Pittsburgh, PA 15232 Shadyside Medical Group
5200 Centre Ave, Pittsburgh, PA 15232


Matthew Schuchert Photo 3

Stem Cell Engraftment-Enhancing Cellular Proteins And Their Uses

US Patent:
2004014, Jul 22, 2004
Filed:
Feb 27, 2003
Appl. No.:
10/375376
Inventors:
Yolonda Colson - Needham MA, US
Matthew Schuchert - Pittsburgh PA, US
Assignee:
University of Pittsburgh
International Classification:
A61K038/17, C07K014/47
US Classification:
514/008000, 530/395000
Abstract:
The present invention relates to the isolation and identification of cellular proteins and protein complexes that promote the engraftment of allogeneic stem cells and the induction of immunologic tolerance in recipient transplant hosts. More specifically, the present invention relates to a novel 33 kD glycoprotein, p33, that can form a complex with the T cell receptor (TCR) chain, alone or in association with the CD3 antigen. The presence of the p33 protein, the TCR/p33 complex or the CD3/TCR/p33 complex of the invention on the surface of cells correlates with the ability of those cells to facilitate allogeneic engraftment in vivo. The compositions and methods of this invention are useful for promoting the engraftment of allogeneic cells and tissues in vivo, for the reduction of Graft Versus Host Disease (GVHD) which occurs in connection with transplantation of allogeneic cells in vivo and for the induction of immunologic tolerance to donor cells and tissue in vivo, e.g., in solid organ or tissue transplantation or in bone marrow transplantation used in connection with the treatment of leukemia or other hematological diseases.